Vikas Sinha - Aug 9, 2021 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Claire Poll, Attorney-in-fact for Vikas Sinha
Stock symbol
VRNA
Transactions as of
Aug 9, 2021
Transactions value $
$0
Form type
4
Date filed
8/10/2021, 04:47 PM
Next filing
Apr 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRNA Share Options (Right to Buy) Award $0 +64K $0.00 64K Aug 9, 2021 Ordinary Shares 64K $0.78 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 The option vests and becomes exercisable as to 25% on August 9, 2021, 25% on November 1, 2021, 25% on February 1, 2022 and 25% on May 1, 2022.